Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.70 |
| ▸ | CA1 | P00915 | 4/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | MMP2 | P08253 | 2/20 | 0.52 |
| ▸ | MMP9 | P14780 | 2/20 | 0.52 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.52 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.52 |
| ▸ | ACE | P12821 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.49 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5260686 | 1.00 | CA2 (0.70) | CA2CA1KMT2AMMP2MMP9 | |
| SCHEMBL2245325 | 0.92 | CA2 (0.69) | CA2CA1KMT2AMMP2MMP9 | |
| SCHEMBL2246061 | 0.92 | CA2 (0.69) | CA2CA1KMT2AMMP2MMP9 | |
| SCHEMBL11519163 | 0.92 | CA2 (0.60) | CA2CA1KMT2AC3AR1ACE | |
| SCHEMBL2248738 | 0.89 | HPGDS (0.60) | CA2CA1KMT2AMMP2MMP9 | |
| SCHEMBL3822939 | 0.88 | CA2 (0.71) | CA2CA1KMT2AC3AR1FOLH1 | |
| SCHEMBL27520712 | 0.88 | CA2 (0.71) | CA2CA1KMT2AC3AR1FOLH1 | |
| SCHEMBL2249554 | 0.87 | CA2 (0.63) | CA2CA1KMT2AMMP2MMP9 | |
| SCHEMBL2242569 | 0.87 | CA2 (0.63) | CA2CA1KMT2AC3AR1 | |
| SCHEMBL715646 | 0.87 | CA2 (0.67) | CA2CA1TDP1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1052968-A4 | $g(a)-AMIDES OF $i(L)-AMINO ACIDS AS FRAGRANCE PRECURSORS | GILLETTE CO (US) | 2004-09-15 | — | — | EP | claimed |
| EP-0815833-B1 | Malodour preventing agents | GIVAUDAN SA (CH) | 2003-04-09 | — | — | EP | claimed |
| EP-1052968-A1 | $g(a)-AMIDES OF $i(L)-AMINO ACIDS AS FRAGRANCE PRECURSORS | THE GILLETTE COMPANY (US) | 2000-11-22 | — | — | EP | claimed |
| US-5932198-A | α-amides of L-amino acids as fragrance precursors | THE GILLETTE COMPANY (US) | 1999-08-03 | — | — | US | claimed |
| US-5925339-A | ODORLESS DEODORANTS AND ANTIPERSPIRANTS | GIVAUDAN ROURE SA (CH) | 1999-07-20 | — | — | US | claimed |
| WO-1999030680-A1 | α-AMIDES OF L-AMINO ACIDS AS FRAGRANCE PRECURSORS | THE GILLETTE COMPANY (US) | 1999-06-24 | — | — | WO | claimed |
| EP-0815833-A2 | Malodour preventing agents | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-01-07 | — | — | EP | claimed |
| CN-112438905-B | Moisturizing and skin-brightening composition and application thereof | 澳思美日用化工（广州）有限公司 | 2021-09-07 | — | — | CN | disclosed |
| CN-112438905-A | Moisturizing and skin-brightening composition and application thereof | 澳思美日用化工（广州）有限公司 | 2021-03-05 | — | — | CN | disclosed |
| EP-1338588-B1 | METHOD OF RESOLVING OPTICAL ISOMERS OF AMINO ACID DERIVATIVE | TOKUYAMA CORP (JP) | 2007-09-26 | — | — | EP | disclosed |
| US-7199264-B2 | Method of resolving optical isomers of amino acid derivative | TOKUYAMA CORPORATION (JP) | 2007-04-03 | — | — | US | disclosed |
| EP-1052968-A4 | $g(a)-AMIDES OF $i(L)-AMINO ACIDS AS FRAGRANCE PRECURSORS | GILLETTE CO (US) | 2004-09-15 | — | — | EP | disclosed |
| US-20040102646-A1 | Method of resolving optical isomers of amino acid derivative | TOKUYAMA CORPORATION (JP) | 2004-05-27 | — | — | US | disclosed |
| EP-0815833-B1 | Malodour preventing agents | GIVAUDAN SA (CH) | 2003-04-09 | — | — | EP | disclosed |
| EP-1052968-A1 | $g(a)-AMIDES OF $i(L)-AMINO ACIDS AS FRAGRANCE PRECURSORS | THE GILLETTE COMPANY (US) | 2000-11-22 | — | — | EP | disclosed |
| US-6150542-A | COSMETICS; IN DEODORIZERS, ANTIPERSPIRANTS | GIVAUDAN ROURE (INTERNATIONAL) SA (CH) | 2000-11-21 | — | — | US | disclosed |
| US-5932198-A | α-amides of L-amino acids as fragrance precursors | THE GILLETTE COMPANY (US) | 1999-08-03 | — | — | US | disclosed |
| US-5925339-A | ODORLESS DEODORANTS AND ANTIPERSPIRANTS | GIVAUDAN ROURE SA (CH) | 1999-07-20 | — | — | US | disclosed |
| WO-1999030680-A1 | α-AMIDES OF L-AMINO ACIDS AS FRAGRANCE PRECURSORS | THE GILLETTE COMPANY (US) | 1999-06-24 | — | — | WO | disclosed |
| EP-0815833-A2 | Malodour preventing agents | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102646-A1 | Method of resolving optical isomers of amino acid derivative | ALAD, AAAS, BCAT1 | CA2 416/4885CA1 203/4885KMT2A 3943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.